Aurora Cannabis (ACBFF) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc. (OTCMKTS:ACBFF) is a Canadian licensed producer of medical and consumer cannabis products. Headquartered in Edmonton, Alberta, the company operates large-scale indoor and greenhouse facilities designed to produce consistent, high-quality cannabis flower and derivative products. Aurora’s operations span cultivation, processing and distribution, with an emphasis on leveraging advanced technologies and proprietary genetics to meet diverse patient and adult-use consumer needs.

The company’s product portfolio includes dried flower, cannabis oils, softgel capsules, vaporizable extracts and pre-rolled offerings. Aurora also supplies clinical-grade cannabinoids for pharmaceutical development, collaborating with academic and industry partners to explore applications in pain management, neurology and oncology. The company maintains rigorous quality assurance standards and Good Manufacturing Practices (GMP) certification to support both domestic sales in Canada and exports to key international markets.

Since its founding in 2013, Aurora has pursued an aggressive expansion strategy, completing strategic acquisitions such as MedReleaf and forming joint ventures in Europe, Latin America and Australia. Its global footprint encompasses agreements to supply medical cannabis in Germany, Denmark and the United Kingdom, among other jurisdictions. Aurora operates research facilities and pilot projects aimed at optimizing cultivation methods, reducing production costs and developing next-generation cannabinoid products.

In recent years, Aurora has undergone leadership transitions to strengthen its operational focus and financial discipline. Under the direction of Chief Executive Officer Miguel Martin, the company continues to streamline its asset base and sharpen its go-to-market strategy. Aurora remains committed to innovation in cultivation science and patient-centric product development as it works to capitalize on evolving regulatory frameworks and expanding global demand for cannabis-based therapies.

Key Stats

• Today's Range: $4.93 to $5.09
• 50-Day Range: $4.21 to $5.62
• 52-Week Range: $2.20 to $12.53
• Volume: 571,963 shs
• Average Volume: 4.22 million shs
• Market Capitalization: $4.80 billion
• P/E Ratio: 41.67
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACBFF Stock Analysis - Frequently Asked Questions

How have ACBFF shares performed this year?

Aurora Cannabis' stock was trading at $4.25 on January 1st, 2025. Since then, ACBFF shares have increased by 17.6% and is now trading at $5.00.

Does Aurora Cannabis have any subsidiaries?

The following companies are subsidiaries of Aurora Cannabis: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and others.

How do I buy shares of Aurora Cannabis?

Shares of ACBFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ACBFF
• CIK: N/A
• Web: auroramj.com
• Phone: 844-928-7672
• Fax: N/A
• Employees: 1,340
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 41.67
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 960,960,000
• Free Float: N/A
• Market Cap: $4.80 billion
• Optionable: Not Optionable
• Beta: N/A